Transcend Medical, Inc. v Glaukos Corporation

Link copied
Case Copied 45 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Transcend Medical, Inc. v Glaukos Corporation [2015] APO 73

Patent Application:                2006336598

Title:Glaucoma Treatment Device

Patent Applicant:                   Transcend Medical, Inc.

Opponent:  Glaukos Corporation

Delegate:  Ed Knock

Decision Date:  9 November 2015

Hearing Date:  25 August 2015, in Canberra

Catchwords:  PATENTS - opposition to grant - system for installing a shunt within an eye to relieve intraocular pressure - claiming by result - broadest claim limited by preferred features - whether full description, clarity and fair basis - whether claims novel in light of cited prior publications - citations not combinable - whether claims involve inventive step in light of the citations - all bar one document would not have been ascertained -  other citation does not point to the present invention - opposition fails on all grounds.

Representation:  Patent applicant:  Christian Dimitriadis SC, instructed by Robert Finzi of Pizzeys, Canberra

Opponent:Trevor Davies, assisted by Tony Shaw, of Allens, Sydney

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                2006336598

Title:Glaucoma Treatment Device

Patent Applicant:                   Transcend Medical, Inc.

Date of Decision:                   9 November 2015

DECISION

Opposition dismissed.  Unless the opponent appeals within 28 days of the date of this decision, I direct that the application proceed to grant.  Costs awarded against the opponent Glaukos Corporation.

REASONS FOR DECISION

Background

1.   Application 2006336598 was filed by Transcend Medical Inc. (Transcend) under the provisions of the Patent Cooperation Treaty, on 22 December 2006, as application PCT/US2006/049234.  It claimed priority from three US patent filings, the earliest filing being on 17 January 2006.  International publication of the PCT application took place on
2 August 2007, the application being accorded the International Publication Number
WO 2007/087061.  The application did not undergo international preliminary examination under the PCT, and instead an International Preliminary Report on Patentability (Chapter I) (IPRPI) was issued on 22 July 2008.  The application entered the national phase in Australia on 8 July 2008, and it was allocated Australian application number 2006336598.  The application was advertised accepted on 10 October 2013.

2.    A notice of opposition to application 2006336598 was filed on 10 January 2014 by Glaukos Corporation (Glaukos), followed by a statement of grounds and particulars on 10 April 2014.   This was subsequently amended to add an eighth citation document to the seven which had been cited in the original statement.   The evidence in support of the opposition was completed on 10 September 2014, and the other evidentiary stages were duly completed on
11 February 2015 without need of extension.

3.    The opposition was heard on 25 August 2015 in Canberra.  The applicant Transcend was represented by Mr Christian Dimitriadis SC, and the opponent Glaukos was represented by Mr Trevor Davies, patent attorney.

The specification

4.   The invention relates to a system for treating the eye disease known as glaucoma.  Glaucoma is the build-up of pressure within the eye due to an excess of the eye’s aqueous humour.  If left untreated it will result in damage to the optic nerve, and eventually blindness.  Treatment strategies focus on reducing the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Transcend Medical, Inc. v Glaukos Corporation and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2015] APO 73
Decision Date

CaseChat Overview and Summary

The case of Transcend Medical, Inc. v Glaukos Corporation involved an opposition to the grant of a patent by Transcend Medical, Inc. against Glaukos Corporation. The patent in question related to a system for installing a shunt within an eye to relieve intraocular pressure. The opposition was heard by the Federal Court of Australia. The primary legal issues the court had to address were whether the patent claims met the requirements of full description, clarity, and fair basis, as well as whether the claims were novel and involved an inventive step in light of the prior art cited.

The court examined whether the broadest claim in the patent was limited by preferred features, ensuring it adhered to the necessary standards for patentability. It determined that the claims, while broad, were sufficiently defined by the preferred features described in the specification, satisfying the requirements for clarity and fair basis. Regarding novelty, the court found that although certain prior publications were cited, they were not combinable in a way that would anticipate the claimed invention. Additionally, the court concluded that the claims involved an inventive step as the cited prior art did not point to the present invention, especially considering that one of the documents would not have been ascertainable at the relevant time.

As a result, the opposition to the grant of the patent failed on all grounds. The court upheld the validity of the patent, affirming that the claims were both novel and involved an inventive step. The decision reinforces the importance of carefully considering the specific features and limitations of patent claims, as well as the relevant prior art in determining patentability.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established